Macquarie Group’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Macquarie Group's OCDX Position: Q2 2022 in Review
Macquarie Group sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 41,177 shares — an estimated $769K sold.
Macquarie Group first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $35.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Macquarie Group reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Macquarie Group sold 41,177 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $769K.
- Macquarie Group first reported a position in Ortho Clinical Diagnostics Holdings in Q2 2021 and held it in 4 quarters.
- Macquarie Group's Ortho Clinical Diagnostics Holdings position peaked at $35.9M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.